Total Payments
$6,720
2024 Payments
$1,587
Companies
48
Transactions
419
Medicare Patients
2,393
Medicare Billing
$141,422
Payment Breakdown by Category
Food & Beverage$6,683 (99.5%)
Education$36.71 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,683 | 417 | 99.5% |
| Education | $36.71 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,045 | 74 | $0 (2024) |
| Amgen Inc. | $875.61 | 52 | $0 (2024) |
| Novo Nordisk Inc | $672.94 | 51 | $0 (2024) |
| Lilly USA, LLC | $613.16 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $411.19 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $295.44 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $277.73 | 18 | $0 (2024) |
| PFIZER INC. | $250.37 | 13 | $0 (2024) |
| Amarin Pharma Inc. | $174.80 | 15 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $165.45 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,587 | 96 | Amgen Inc. ($224.46) |
| 2023 | $1,855 | 110 | ABBVIE INC. ($280.84) |
| 2022 | $1,560 | 98 | Amgen Inc. ($232.47) |
| 2021 | $1,717 | 115 | AbbVie Inc. ($351.04) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Biological | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Bone Health | ||||||
| 09/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Gastroenterology | ||||||
| 09/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Gastroenterology | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 646 | 893 | $71,450 | $38,496 |
| 2022 | 11 | 637 | 848 | $67,207 | $36,265 |
| 2021 | 10 | 570 | 800 | $72,671 | $36,215 |
| 2020 | 8 | 540 | 746 | $57,951 | $30,447 |
Total Patients
2,393
Total Services
3,287
Medicare Billing
$141,422
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 275 | $36,992 | $18,699 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 88 | 88 | $11,647 | $9,011 | 77.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 94 | 94 | $8,604 | $5,958 | 69.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 93 | 93 | $4,836 | $1,332 | 27.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 91 | 91 | $4,556 | $1,303 | 28.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 36 | 104 | $1,659 | $990.08 | 59.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $1,170 | $685.32 | 58.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 94 | 109 | $1,635 | $371.69 | 22.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 11 | 13 | $189.00 | $79.43 | 42.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 11 | 13 | $162.00 | $66.04 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 257 | $33,962 | $17,070 | 50.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 82 | 82 | $10,936 | $8,552 | 78.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 88 | 88 | $8,064 | $5,934 | 73.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 84 | 84 | $4,368 | $1,229 | 28.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 81 | 81 | $4,058 | $1,165 | 28.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 35 | 89 | $1,379 | $853.07 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 21 | $1,936 | $835.84 | 43.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 84 | 92 | $1,380 | $315.52 | 22.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 16 | 18 | $266.00 | $110.34 | 41.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 18 | $630.00 | $108.72 | 17.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 16 | 18 | $228.00 | $91.74 | 40.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 266 | $40,567 | $18,617 | 45.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 74 | 74 | $9,341 | $7,902 | 84.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 77 | 77 | $8,706 | $5,287 | 60.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 72 | 72 | $3,736 | $1,060 | 28.4% |
About Amanda Stephens, NP
Amanda Stephens, NP is a Family healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1194148767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Stephens, NP has received a total of $6,720 in payments from pharmaceutical and medical device companies, with $1,587 received in 2024. These payments were reported across 419 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,683).
As a Medicare-enrolled provider, Stephens has provided services to 2,393 Medicare beneficiaries, totaling 3,287 services with total Medicare billing of $141,422. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Athens, GA
- Active Since 02/01/2014
- Last Updated 02/01/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1194148767
Products in Payments
- JARDIANCE (Drug) $489.46
- EVENITY (Biological) $433.96
- UBRELVY (Drug) $369.76
- Otezla (Drug) $350.52
- VRAYLAR (Drug) $327.78
- NURTEC ODT (Drug) $302.48
- TRELEGY ELLIPTA (Drug) $295.44
- XIFAXAN (Drug) $277.73
- QULIPTA (Drug) $266.86
- Ozempic (Drug) $257.18
- TRULICITY (Drug) $213.00
- Vascepa (Drug) $174.80
- Wegovy (Drug) $165.50
- QUVIVIQ (Drug) $159.86
- Rybelsus (Drug) $149.18
- TRINTELLIX (Drug) $140.84
- Kerendia (Drug) $137.44
- MOUNJARO (Drug) $123.85
- FARXIGA (Drug) $107.43
- Aimovig (Biological) $91.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Athens
Amanda Pack, Np, NP
Family — Payments: $13,342
Family $13,342
Katelyn Gillespie, Np, NP
Family — Payments: $10,429
Family $10,429
Mona Olive, Fnp, FNP
Family — Payments: $9,229
Family $9,229
Mary Mongare, Fnp-C, FNP-C
Family — Payments: $8,110
Family $8,110
Christen Mccabe, Fnp, FNP
Family — Payments: $7,587
Family $7,587
Mrs. Jamie Williams, Msn, Np-C, MSN, NP-C
Family — Payments: $6,025
Family $6,025